Parul Gandhi, MD
Assistant Professor of Internal Medicine (Cardiovascular); Associate Fellowship Program Director, Cardiovascular Medicine; Director, Cardiology Consult Service, VA Cardiology; Director, CHF Transitional Care Clinic, VA Cardiology; Director, VA cardiology elective for medical students, VA Cardiology
Research & Publications
Biography
News
Coauthors
Selected Publications
- Hospitalisations for heart failure: increased palliative care referrals - a veterans affairs hospital initiative.Gruen J, Gandhi P, Gillespie-Heyman S, Shamas T, Adelman S, Ruskin A, Bauer M, Merchant N. Hospitalisations for heart failure: increased palliative care referrals - a veterans affairs hospital initiative. BMJ Supportive & Palliative Care 2023, spcare-2022-004118. PMID: 36609533, DOI: 10.1136/spcare-2022-004118.
- Longitudinal Patterns of Specialist Palliative Care Provision in the HEART-PAL Cohort (GP716)Feder S, Murphy T, Abel E, Ersek M, Gandhi P, Fried T, Redeker N, Akgün K. Longitudinal Patterns of Specialist Palliative Care Provision in the HEART-PAL Cohort (GP716). Journal Of Pain And Symptom Management 2022, 63: 1120-1121. DOI: 10.1016/j.jpainsymman.2022.04.107.
- Cardiovascular BiomarkersGandhi P, Januzzi Jr J. Cardiovascular Biomarkers. DeckerMed Medicine 2022 DOI: 10.2310/im.1405.
- Cardiovascular BiomarkersGandhi P, Januzzi Jr J. Cardiovascular Biomarkers. DeckerMed Medicine Cardiovascular Medicine 2022 DOI: 10.2310/7900.1405.
- Cardiovascular BiomarkersGandhi P, Januzzi Jr J. Cardiovascular Biomarkers. DeckerMed Transitional Year Weekly Curriculum™ 2022 DOI: 10.2310/tywc.1405.
- SEX DIFFERENCES IN NATRIURETIC PEPTIDE TESTING IN PATIENTS HOSPITALIZED WITH HEART FAILUREGandhi P, Runels T, Skanderson M, Bastian L, Brandt C, Hauser R, Feder S, Rodwin B, Farmer M, Bean-Mayberry B, Akgun K. SEX DIFFERENCES IN NATRIURETIC PEPTIDE TESTING IN PATIENTS HOSPITALIZED WITH HEART FAILURE. Journal Of The American College Of Cardiology 2022, 79: 467. DOI: 10.1016/s0735-1097(22)01458-9.
- Abstract 10311: Increasing Inpatient Palliative Care Referrals for Veterans with Heart Failure: A Quality Improvement InitiativeGruen J, Merchant N, Gillespie-Heyman S, Shamas T, Adelman S, Bauer M, Ruskin A, Gandhi P. Abstract 10311: Increasing Inpatient Palliative Care Referrals for Veterans with Heart Failure: A Quality Improvement Initiative. Circulation 2021, 144: a10311-a10311. DOI: 10.1161/circ.144.suppl_1.10311.
- HOSPITAL VARIATIONS IN TROPONIN ORDERING AND ITS ASSOCIATION WITH DOWNSTREAM RESOURCE UTILIZATION WITHIN THE VETERANS HEALTH ADMINISTRATIONChui P, Bastian L, Gandhi P, Esserman D, Miller E, Hauser R. HOSPITAL VARIATIONS IN TROPONIN ORDERING AND ITS ASSOCIATION WITH DOWNSTREAM RESOURCE UTILIZATION WITHIN THE VETERANS HEALTH ADMINISTRATION. Journal Of The American College Of Cardiology 2019, 73: 178. DOI: 10.1016/s0735-1097(19)30786-7.
- HOSPITAL VARIATIONS IN THE UTILIZATION OF CARDIAC STRESS TESTING FOR PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITHIN THE VETERANS HEALTH ADMINISTRATIONChui P, Hauser R, Miller E, Esserman D, Bastian L, Gandhi P. HOSPITAL VARIATIONS IN THE UTILIZATION OF CARDIAC STRESS TESTING FOR PATIENTS PRESENTING TO THE EMERGENCY DEPARTMENT WITHIN THE VETERANS HEALTH ADMINISTRATION. Journal Of The American College Of Cardiology 2019, 73: 177. DOI: 10.1016/s0735-1097(19)30785-5.
- MULTIPLE BIOMARKERS FOR PREDICTING MAJOR ADVERSE CARDIAC EVENTS IN AT-RISK PATIENTS UNDERGOING DIAGNOSTIC CORONARY ANGIOGRAPHY: RESULTS FROM THE CATHETER SAMPLED BLOOD ARCHIVE IN CARDIOVASCULAR DISEASES (CASABLANCA) STUDYMcCarthy C, Van Kimmenade R, Gaggin H, Simon M, Ibrahim N, Gandhi P, Kelly N, Belcher A, Motiwala S, Rhyne R, Magaret C, Januzzi J. MULTIPLE BIOMARKERS FOR PREDICTING MAJOR ADVERSE CARDIAC EVENTS IN AT-RISK PATIENTS UNDERGOING DIAGNOSTIC CORONARY ANGIOGRAPHY: RESULTS FROM THE CATHETER SAMPLED BLOOD ARCHIVE IN CARDIOVASCULAR DISEASES (CASABLANCA) STUDY. Journal Of The American College Of Cardiology 2017, 69: 78. DOI: 10.1016/s0735-1097(17)33467-8.
- Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection FractionGandhi PU, Chow SL, Rector TS, Krum H, Gaggin HK, McMurray JJ, Zile MR, Komajda M, McKelvie RS, Carson PE, Januzzi JL, Anand IS. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction. Journal Of Cardiac Failure 2016, 23: 20-28. PMID: 27317843, DOI: 10.1016/j.cardfail.2016.06.006.
- The Importance of Worsening Heart Failure in Ambulatory Patients Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided TherapyMallick A, Gandhi PU, Gaggin HK, Ibrahim N, Januzzi JL. The Importance of Worsening Heart Failure in Ambulatory Patients Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy. JACC Heart Failure 2016, 4: 749-755. PMID: 27179830, DOI: 10.1016/j.jchf.2016.03.012.
- ASSESSMENT OF SERIAL HEART RATE AND BETA BLOCKER USE IN A CONTEMPORARY CHRONIC SYSTOLIC HEART FAILURE PATIENTS: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE (PROTECT) STUDYGaggin H, Rabideau D, Ibrahim N, Gandhi P, Januzzi J. ASSESSMENT OF SERIAL HEART RATE AND BETA BLOCKER USE IN A CONTEMPORARY CHRONIC SYSTOLIC HEART FAILURE PATIENTS: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE (PROTECT) STUDY. Journal Of The American College Of Cardiology 2016, 67: 1316. DOI: 10.1016/s0735-1097(16)31317-1.
- COMPREHENSIVE ASSESSMENT OF TYPE 2 MYOCARDIAL INFARCTION IN AT-RISK PATIENTS: RESULTS FROM THE CATHETER SAMPLED BLOOD ARCHIVE IN CARDIOVASCULAR DISEASES (CASABLANCA) STUDYGaggin H, Liu Y, Lyass A, Van Kimmenade R, Motiwala S, Kelly N, Mallick A, Gandhi P, Ibrahim N, Simon M, Belcher A, Harisiades J, Massaro J, D’Agostino R, Januzzi J. COMPREHENSIVE ASSESSMENT OF TYPE 2 MYOCARDIAL INFARCTION IN AT-RISK PATIENTS: RESULTS FROM THE CATHETER SAMPLED BLOOD ARCHIVE IN CARDIOVASCULAR DISEASES (CASABLANCA) STUDY. Journal Of The American College Of Cardiology 2016, 67: 282. DOI: 10.1016/s0735-1097(16)30283-2.
- Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary SyndromeHuffman JC, Beale EE, Celano CM, Beach SR, Belcher AM, Moore SV, Suarez L, Motiwala SR, Gandhi PU, Gaggin HK, Januzzi JL. Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome. Circulation Cardiovascular Quality And Outcomes 2015, 9: 55-63. PMID: 26646818, PMCID: PMC4720551, DOI: 10.1161/circoutcomes.115.002184.
- Abstract 14299: The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) TrialGandhi P, Chow S, Rector T, Krum H, Gaggin H, McMurray J, Zile M, Komajda M, McKelvie R, Carson P, Januzzi J, Anand I. Abstract 14299: The Prognostic Value of Insulin-like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Ejection Fraction: Results From Irbesartan in Heart Failure and Preserved Ejection Fraction (I-PRESERVE) Trial. Circulation 2015, 132 DOI: 10.1161/circ.132.suppl_3.14299.
- Abstract 17028: “Worsening Heart Failure” in Chronic Heart Failure With Reduced Ejection Fraction: Definition, Characteristics, and Effects of NT-proBNP Guided TherapyMallick A, Gandhi P, Gaggin H, Januzzi J. Abstract 17028: “Worsening Heart Failure” in Chronic Heart Failure With Reduced Ejection Fraction: Definition, Characteristics, and Effects of NT-proBNP Guided Therapy. Circulation 2015, 132 DOI: 10.1161/circ.132.suppl_3.17028.
- Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with DyspneaAlba GA, Truong QA, Gaggin HK, Gandhi PU, De Berardinis B, Magrini L, Bajwa EK, Di Somma S, Januzzi JL, Network G. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea. The American Journal Of Medicine 2015, 129: 96-104.e7. PMID: 26169892, DOI: 10.1016/j.amjmed.2015.06.037.
- Design and baseline data from the Gratitude Research in Acute Coronary Events (GRACE) studyHuffman JC, Beale EE, Beach SR, Celano CM, Belcher AM, Moore SV, Suarez L, Gandhi PU, Motiwala SR, Gaggin H, Januzzi JL. Design and baseline data from the Gratitude Research in Acute Coronary Events (GRACE) study. Contemporary Clinical Trials 2015, 44: 11-19. PMID: 26166171, PMCID: PMC4707130, DOI: 10.1016/j.cct.2015.07.002.
- Natriuretic Peptides for Diagnosis, Prognosis, and Management of Heart FailureGandhi P, Januzzi Jr. J. Natriuretic Peptides for Diagnosis, Prognosis, and Management of Heart Failure. 2015, 731-756. DOI: 10.1007/978-94-007-7696-8_12.
- Concentrations of Highly Sensitive Cardiac Troponin-I Predict Poor Cardiovascular Outcomes and Adverse Remodeling in Chronic Heart FailureMotiwala SR, Gaggin HK, Gandhi PU, Belcher A, Weiner RB, Baggish AL, Szymonifka J, Januzzi JL. Concentrations of Highly Sensitive Cardiac Troponin-I Predict Poor Cardiovascular Outcomes and Adverse Remodeling in Chronic Heart Failure. Journal Of Cardiovascular Translational Research 2015, 8: 164-172. PMID: 25777344, DOI: 10.1007/s12265-015-9618-4.
- Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failureGandhi PU, Gaggin HK, Belcher AM, Harisiades JE, Basile A, Falco A, Rosati A, Piscione F, Januzzi JL, Turco MC. Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failure. Clinica Chimica Acta 2015, 445: 73-78. PMID: 25753466, DOI: 10.1016/j.cca.2015.02.048.
- BCL-2-ASSOCIATED ATHANOGENE 3 CONCENTRATIONS ARE PROGNOSTIC IN PATIENTS WITH ACUTELY DECOMPENSATED HEART FAILUREGandhi P, Gaggin H, Belcher A, Basile A, Falco A, Rosati A, Januzzi J, Turco M. BCL-2-ASSOCIATED ATHANOGENE 3 CONCENTRATIONS ARE PROGNOSTIC IN PATIENTS WITH ACUTELY DECOMPENSATED HEART FAILURE. Journal Of The American College Of Cardiology 2015, 65: a1007. DOI: 10.1016/s0735-1097(15)61007-5.
- ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTIONGandhi P, Motiwala S, Belcher A, Gaggin H, Weiner R, Baggish A, Fiuzat M, Rocca H, Januzzi J. ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION. Journal Of The American College Of Cardiology 2015, 65: a970. DOI: 10.1016/s0735-1097(15)60970-6.
- SERIAL MEASUREMENT OF TUMOR NECROSIS FACTOR-α, INTERLEUKIN-6 AND VASCULAR ENDOTHELIAL GROWTH FACTOR AS A FUNCTION OF CACHEXIA IN PATIENTS WITH CHRONIC HEART FAILURE: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE (PROTECT) STUDYBelcher A, Gandhi P, Januzzi J, Gaggin H. SERIAL MEASUREMENT OF TUMOR NECROSIS FACTOR-α, INTERLEUKIN-6 AND VASCULAR ENDOTHELIAL GROWTH FACTOR AS A FUNCTION OF CACHEXIA IN PATIENTS WITH CHRONIC HEART FAILURE: RESULTS FROM THE PROBNP OUTPATIENT TAILORED CHRONIC HEART FAILURE (PROTECT) STUDY. Journal Of The American College Of Cardiology 2015, 65: a990. DOI: 10.1016/s0735-1097(15)60990-1.
- Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunctionGandhi PU, Motiwala SR, Belcher AM, Gaggin HK, Weiner RB, Baggish AL, Fiuzat M, Rocca H, Januzzi JL. Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction. American Heart Journal 2015, 169: 404-411.e3. PMID: 25728731, DOI: 10.1016/j.ahj.2014.12.012.
- Design, methods, baseline characteristics and interim results of the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) studyGaggin H, Bhardwaj A, Belcher A, Motiwala S, Gandhi P, Simon M, Kelly N, Anderson A, Garasic J, Danik S, Schwamm L, Gerszten R, van Kimmenade R, Januzzi J. Design, methods, baseline characteristics and interim results of the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. IJC Metabolic & Endocrine 2014, 5: 11-18. DOI: 10.1016/j.ijcme.2014.08.005.
- Clinical Impact of Atrial Fibrillation in Patients With the HeartMate II Left Ventricular Assist DeviceEnriquez AD, Calenda B, Gandhi PU, Nair AP, Anyanwu AC, Pinney SP. Clinical Impact of Atrial Fibrillation in Patients With the HeartMate II Left Ventricular Assist Device. Journal Of The American College Of Cardiology 2014, 64: 1883-1890. PMID: 25444141, DOI: 10.1016/j.jacc.2014.07.989.
- Characterization and Prediction of Adverse Events From Intensive Chronic Heart Failure Management and Effect on Quality of Life: Results From the Pro-B-Type Natriuretic Peptide Outpatient-Tailored Chronic Heart Failure Therapy (PROTECT) StudyGandhi PU, Szymonifka J, Motiwala SR, Belcher AM, Januzzi JL, Gaggin HK. Characterization and Prediction of Adverse Events From Intensive Chronic Heart Failure Management and Effect on Quality of Life: Results From the Pro-B-Type Natriuretic Peptide Outpatient-Tailored Chronic Heart Failure Therapy (PROTECT) Study. Journal Of Cardiac Failure 2014, 21: 9-15. PMID: 25463415, DOI: 10.1016/j.cardfail.2014.10.008.
- Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function?Gandhi PU, Gaggin HK, Sheftel AD, Belcher AM, Weiner RB, Baggish AL, Motiwala SR, Liu PP, Januzzi JL. Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function? The American Journal Of Cardiology 2014, 114: 1543-1549. PMID: 25248814, DOI: 10.1016/j.amjcard.2014.08.018.
- Characterization and Prediction of Adverse Events from Intensive Chronic Heart Failure Management with and without NT-proBNP Guidance: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) StudyGandhi P, Szymonifka J, Motiwala S, Belcher A, Januzzi J, Gaggin H. Characterization and Prediction of Adverse Events from Intensive Chronic Heart Failure Management with and without NT-proBNP Guidance: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study. Journal Of Cardiac Failure 2014, 20: s51-s52. DOI: 10.1016/j.cardfail.2014.06.146.
- THE CLINICAL IMPACT OF ATRIAL FIBRILLATION IN PATIENTS WITH THE HEARTMATE II LEFT VENTRICULAR ASSIST DEVICEEnriquez A, Calenda B, Gandhi P, Nair A, Anyanwu A, Pinney S. THE CLINICAL IMPACT OF ATRIAL FIBRILLATION IN PATIENTS WITH THE HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE. Journal Of The American College Of Cardiology 2014, 63: a888. DOI: 10.1016/s0735-1097(14)60888-3.
- INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7 IN HEART FAILURE PATIENTS: A NOVEL BIOMARKER OF MYOCARDIAL DIASTOLIC FUNCTION?Gandhi P, Motiwala S, Sheftel A, Weiner R, Baggish A, Gaggin H, Liu P, Januzzi J. INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN 7 IN HEART FAILURE PATIENTS: A NOVEL BIOMARKER OF MYOCARDIAL DIASTOLIC FUNCTION? Journal Of The American College Of Cardiology 2014, 63: a788. DOI: 10.1016/s0735-1097(14)60788-9.
- (518) The Clinical Impact of Atrial Fibrillation in Patients with the HeartMate II Left Ventricular Assist DeviceEnriquez A, Brandon C, Gandhi P, Nair A, Anyanwu A, Pinney S. (518) The Clinical Impact of Atrial Fibrillation in Patients with the HeartMate II Left Ventricular Assist Device. The Journal Of Heart And Lung Transplantation 2014, 33: s193. DOI: 10.1016/j.healun.2014.01.525.
- Natriuretic Peptides for Diagnosis, Prognosis, and Management of Heart FailureGandhi P, Januzzi Jr. J. Natriuretic Peptides for Diagnosis, Prognosis, and Management of Heart Failure. 2014, 1-21. DOI: 10.1007/978-94-007-7740-8_12-1.